These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 11892686

  • 1. Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication.
    Smith JA.
    Clin Cardiol; 2002 Mar; 25(3):91-4. PubMed ID: 11892686
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG, Ware JE, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR.
    J Am Geriatr Soc; 2002 Dec; 50(12):1939-46. PubMed ID: 12473004
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
    Squires H, Simpson E, Meng Y, Harnan S, Stevens J, Wong R, Thomas S, Michaels J, Stansby G.
    Health Technol Assess; 2011 Dec; 15(40):1-210. PubMed ID: 22142554
    [Abstract] [Full Text] [Related]

  • 6. Cilostazol for intermittent claudication.
    Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G.
    Cochrane Database Syst Rev; 2014 Oct 31; 2014(10):CD003748. PubMed ID: 25358850
    [Abstract] [Full Text] [Related]

  • 7. Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6.
    Lee TM, Su SF, Hwang JJ, Tseng CD, Chen MF, Lee YT, Wang SS.
    Atherosclerosis; 2001 Oct 31; 158(2):471-6. PubMed ID: 11583728
    [Abstract] [Full Text] [Related]

  • 8. Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.
    Grouse JR, Allan MC, Elam MB.
    J Clin Pharmacol; 2002 Dec 31; 42(12):1291-8. PubMed ID: 12463722
    [Abstract] [Full Text] [Related]

  • 9. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR, Herd JA, Isaacsohn JL, Davidson M, Cutler B, Heckman J, Forbes WP.
    J Vasc Surg; 1998 Feb 31; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [Abstract] [Full Text] [Related]

  • 10. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE, Bortey EB, Forbes WP.
    Arch Intern Med; 1999 Sep 27; 159(17):2041-50. PubMed ID: 10510990
    [Abstract] [Full Text] [Related]

  • 11. Cilostazol: treatment of intermittent claudication.
    Reilly MP, Mohler ER.
    Ann Pharmacother; 2001 Jan 27; 35(1):48-56. PubMed ID: 11197586
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endovascular revascularisation versus conservative management for intermittent claudication.
    Fakhry F, Fokkenrood HJ, Spronk S, Teijink JA, Rouwet EV, Hunink MGM.
    Cochrane Database Syst Rev; 2018 Mar 08; 3(3):CD010512. PubMed ID: 29518253
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cilostazol for peripheral arterial disease.
    Robless P, Mikhailidis DP, Stansby GP.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003748. PubMed ID: 17253494
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cilostazol: a review of its use in intermittent claudication.
    Chapman TM, Goa KL.
    Am J Cardiovasc Drugs; 2003 Jan 24; 3(2):117-38. PubMed ID: 14727939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM, Su SF, Tsai CH, Lee YT, Wang SS.
    Clin Sci (Lond); 2001 Sep 24; 101(3):305-11. PubMed ID: 11524048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.